Biology 9700/42 — October/November 2025

Background Concept

Rice (Oryza sativa) is a semi-aquatic crop that thrives in the flooded paddy fields where most other crops would suffocate. Three connected adaptations make this possible.

1. Low oxygen in flooded soils. Oxygen diffuses about 10 000 times more slowly through water than through air, so once the soil pores are filled with water the O₂ supply to root cells is cut off. The roots are forced to switch to anaerobic respiration, which in plant cells produces ethanol (and CO₂) rather than the lactate made by animal cells.
2. A toxic waste product. Ethanol is harmful: it denatures proteins and disrupts membrane integrity. Rice roots synthesise ethanol dehydrogenase to detoxify it (see part (b)).
3. Aerenchyma. This is a spongy parenchyma tissue full of large interconnected air spaces. In rice, aerenchyma runs continuously from the leaves, through the stems, down into the roots. It acts as an internal snorkel, letting O₂ (from photosynthesis or from the atmosphere) diffuse down to the submerged tissues, while waste gases (CO₂, methane, ethylene) diffuse out.

Understanding the Question

The flow chart (Fig. 1.1) labels three unknowns, A, B and C. With reference to it we must name:

• A — a substance whose soil concentration falls in flooded fields (something normally absorbed from aerated soil).
• B — a waste product that builds up inside root cells under flooded conditions.
• C — a tissue found in stems and roots, whose presence is linked to flooding.

Approach

Think about (i) what is missing in waterlogged soil, (ii) what plant cells produce when oxygen is scarce, and (iii) what internal plumbing rice uses to keep its tissues supplied with air.

Step-by-Step Reasoning

• A = oxygen. Water displaces air from soil pores, so the O₂ concentration around the root surface falls. The root cells' aerobic respiration is therefore impaired.
• B = ethanol. With no O₂, glycolysis can still run, but pyruvate cannot enter the link reaction / Krebs cycle. Plant cells instead decarboxylate pyruvate to acetaldehyde (releasing CO₂) and then reduce the acetaldehyde to ethanol, regenerating NAD⁺ so that glycolysis can continue. Ethanol is therefore the characteristic waste product of anaerobic respiration in plant cells.
• C = aerenchyma. This air-filled parenchyma forms in stems and roots of rice and provides a low-resistance internal pathway for O₂ to reach submerged tissues and for gases to escape.

Key Takeaways

• Rice survives waterlogging through both anatomical (aerenchyma) and biochemical (anaerobic respiration to ethanol) adaptations.
• Anaerobic respiration in plant cells yields ethanol, not lactate (the animal pathway).
• Aerenchyma is the diagnostic tissue of aquatic and semi-aquatic plants.

Common Mistakes

• Writing "lactate" instead of "ethanol" for substance B — that is the animal pathway, not the plant one.
• Naming "xylem" or "phloem" for tissue C — these are vascular tissues, not the air-filled aerenchyma.
• Confusing aerenchyma with the spongy mesophyll of a leaf.

Things to Be Careful About

• The question says "with reference to Fig. 1.1" — each answer must be deducible from the flow chart's flooded-field scenario plus your prior knowledge of rice biology.
• "Aerenchyma" must be spelled correctly; misspellings are not credited.

Background Concept

Ethanol is a toxic waste product: at high intracellular concentrations it denatures proteins and disrupts membrane integrity. Plant cells that perform anaerobic respiration must therefore dispose of the ethanol as it is made. The key enzyme is ethanol dehydrogenase (also accepted: alcohol dehydrogenase), which catalyses:

The acetaldehyde can then be further oxidised to acetate and fed into normal metabolism. By keeping the ethanol concentration low, this enzyme prevents self-poisoning of the root cell.

Understanding the Question

"Substance B" was identified as ethanol in part (a). The question asks how the root cells respond to a high concentration of ethanol — i.e., what molecular/enzymatic mechanism they use to deal with it. The mark scheme rewards a single creditable point: the name of the enzyme that breaks ethanol down.

Approach

Recall the specific enzyme that detoxifies ethanol in plant cells and state it clearly. No further reasoning is needed for the mark.

Step-by-Step Reasoning

• Root cells exposed to flooding produce large amounts of ethanol by anaerobic respiration.
• They respond by synthesising ethanol dehydrogenase, which catalyses the breakdown of ethanol into acetaldehyde.
• This keeps the intracellular ethanol concentration below toxic levels, so the root cells continue to function (even if only anaerobically).

Key Takeaways

• Anaerobic respiration is a controlled process: even in O₂ deficiency the cell is not simply accumulating waste.
• Many toxic small molecules in cells are handled by a specific dehydrogenase.

Common Mistakes

• Saying the cells "store" the ethanol or "release it into the soil" — neither is the mark-scheme answer.
• Naming the wrong enzyme, e.g. pyruvate dehydrogenase (this operates in aerobic respiration).
• Spelling "ethanol" as "ethanal" (ethanal is acetaldehyde — a different molecule).

Things to Be Careful About

• The mark scheme accepts either ethanol dehydrogenase or alcohol dehydrogenase — both are valid names for the same enzyme.

Background Concept

Three of the most fundamental terms in genetics are gene, genotype and phenotype. They form a logical chain:

• A gene is the unit of inheritance. In molecular terms it is a length of DNA whose sequence of bases is read (transcribed and translated) to produce a specific polypeptide, which may function as part of a protein. A gene therefore has a defined location (locus) on a chromosome, and can exist in different versions called alleles.
• The genotype is the set of alleles an organism carries. For any one gene the genotype is conventionally written as the two alleles present (e.g. AA, Aa or aa) — one inherited from each parent on homologous chromosomes.
• The phenotype is what you can actually see or measure about the organism — its morphology, physiology, behaviour, or any other observable characteristic. The phenotype results from the interaction of the genotype with the environment, but for a single-gene Mendelian trait we describe it simply as the visible expression (e.g. tall, short, smooth, wrinkled).

Understanding the Question

Part (a) is a pure recall item. The command word explain (in the sense of define here) requires one precise sentence per term, using the CIE-accepted wording so each mark is secured. There is no diagram or calculation needed.

Approach

For each term, give the textbook definition in its shortest, most accurate form. The mark scheme rewards:

• "gene" — a section of DNA / sequence of bases coding for a (specific) polypeptide
• "genotype" — all the alleles / the (two) alleles of one gene
• "phenotype" — observable features / characteristics (of an organism)

Step-by-Step Reasoning

1. Gene — The mark scheme's key idea is the link between a piece of DNA and the polypeptide it specifies. Saying merely "a piece of DNA" or "a unit of inheritance" is too vague and may not earn the mark; the function (coding for a polypeptide) is what makes the definition complete.
2. Genotype — The mark scheme accepts either "all the alleles of an organism" or, more narrowly, "the (two) alleles of one gene". A common error is to confuse this with the phenotype or to write only the letters (e.g. "Aa") without saying they represent alleles.
3. Phenotype — Acceptable answers include features, characteristics, traits or appearance. The qualifier "observable" is what distinguishes phenotype from genotype, which is the genetic constitution itself and not directly seen.

Key Takeaways

• gene → DNA → polypeptide
• genotype → the alleles an organism has
• phenotype → what an organism looks/appears like

Common Mistakes

• Defining a gene as "a unit of inheritance" without mentioning DNA or a polypeptide product — loses the molecular precision the mark scheme wants.
• Confusing genotype with phenotype, or describing the genotype as "the genes an organism has" rather than its alleles.
• Describing the phenotype as the alleles or the DNA, rather than the observable outcome.

Things to Be Careful About

• The CIE mark scheme accepts "features / characteristics / traits / appearance" interchangeably for phenotype — any one of these is fine, but do not use vague terms such as "looks" without further qualification.
• Spelling of "phenotype" and "genotype" is occasionally marked; ensure the endings are correct.

Background Concept

A monohybrid cross follows the inheritance of a single gene, where each parent contributes one of two alleles (one dominant, one recessive). Gregor Mendel's experimental design — start with true-breeding parents, generate an F1, then cross the F1 to obtain an F2 — reveals the segregation of alleles at meiosis and the re-emergence of the recessive phenotype in F2. The classic F2 genotypic ratio is 1 : 2 : 1 (AA : Aa : aa) and the phenotypic ratio is 3 : 1 (dominant : recessive).

Key terms to keep clear:

• Homozygous: two identical alleles at a locus (AA or aa).
• Heterozygous: two different alleles at a locus (Aa).
• Dominant allele (A): expressed in the phenotype even when paired with a recessive allele.
• Recessive allele (a): only expressed in the phenotype when homozygous (aa).

Understanding the Question

Part (b) has two components:

1. Outline the procedure of a monohybrid cross (the breeding strategy, generation by generation).
2. State the F2 genotype percentages under simple autosomal dominant/recessive inheritance.

The command words are outline (give the key steps in logical order) and state (give the value). Both require the mark-scheme points, in the right order, with no padding.

Approach

The strategy is the textbook Mendelian sequence:

1. Start with homozygous parents of contrasting phenotypes (AA × aa).
2. Read off the F1 — all heterozygotes displaying the dominant phenotype.
3. Cross F1 × F1 to get F2.
4. Apply a Punnett square to deduce the F2 genotype proportions.

The mark scheme awards four marks for the outline (any four of the listed points) and one mark for the F2 percentages.

Step-by-Step Reasoning

Outline (any four of the following points):

1. Mate/breed/cross homozygous parents. True-breeding individuals are essential so that the parental genotypes are known with certainty.
2. Cross a dominant parent with a recessive parent. This sets up the contrasting phenotypes that will reveal which allele is dominant.
3. To produce the F1 generation. The F1 are all the direct offspring of the P-generation cross.
4. The F1 are all heterozygotes. Each F1 inherits one A from the dominant parent and one a from the recessive parent, so every F1 is Aa.
5. Cross the F1 (or self an F1 plant) to produce the F2. The F2 is the second filial generation; it reveals segregation of the two alleles.

F2 percentages (one mark, but with three required elements):

A Punnett square for Aa × Aa gives four equally likely boxes:

That is 1 AA : 2 Aa : 1 aa, which converts to 25% AA, 50% Aa, 25% aa. All three proportions must be stated for the mark.

Note: the corresponding phenotypic ratio is 3 dominant : 1 recessive, but the question specifically asks for genotype percentages.

Key Takeaways

• A monohybrid cross begins with homozygous parents of contrasting phenotypes.
• F1 are uniformly heterozygous; F2 shows segregation with a 1:2:1 genotypic ratio.
• Each genotypic class is a quarter (25%) of the F2; heterozygotes, being two of the four boxes, are 50%.
• The 3:1 phenotypic ratio follows automatically from dominance but is not what the question asks for here.

Common Mistakes

• Crossing F1 with a parent (a back-cross or test cross) instead of F1 × F1 — this is a different experiment and would not give the 1:2:1 ratio.
• Stating the F2 phenotype percentages (75% dominant, 25% recessive) when the question asks for genotype percentages — common slip; re-read the stem.
• Saying "25% are AA, 25% are Aa and 25% are aa" (which sums to 75%) instead of recognising that heterozygotes occupy 2 of the 4 boxes (= 50%).
• Describing the cross without naming the generations (P, F1, F2) — mark scheme credits the use of these terms.
• Forgetting that self-pollination of an F1 plant is equivalent to F1 × F1.

Things to Be Careful About

• Use precise CIE genetic notation: capital letter for the dominant allele (e.g. A), lower-case for the recessive (e.g. a). Each genotype should be a pair of alleles (AA, Aa, aa).
• The mark scheme explicitly credits either the percentages (25/50/25) or the ratio (1:2:1); give both for safety.
• Homozygous parents must be true-breeding — a single qualifier such as "homozygous" is sufficient on the mark scheme, but a stronger answer says "homozygous dominant × homozygous recessive" so the genotypes are unambiguous.
• The question stipulates autosomal dominant/recessive inheritance, so no sex-linkage considerations are needed.

Background Concept

Bacteria can become resistant to antibiotics through two fundamentally different routes:

1. Mutation — a spontaneous change in the bacterium's own DNA. Mutations arise randomly during DNA replication and can alter the target of the antibiotic (e.g. a ribosomal protein or cell-wall synthesis enzyme), reduce uptake of the drug, or activate an enzyme that breaks the antibiotic down. Because bacterial populations are enormous and reproduce very rapidly, useful resistance mutations can appear within days.

2. Horizontal gene transfer (HGT) — the bacterium acquires a ready-made resistance gene from another bacterium, even of a different species. HGT occurs by three main mechanisms:

   • Conjugation — direct transfer of a plasmid (often carrying resistance genes) from a donor to a recipient cell via a sex pilus.
   • Transformation — uptake of free pieces of DNA released into the environment when other bacteria lyse.
   • Transduction — transfer of bacterial DNA from one cell to another by a bacteriophage.

Resistance genes spread rapidly through bacterial populations because HGT can move them between unrelated lineages, not just between parent and offspring.

Understanding the Question

The question simply asks the candidate to name two ways a bacterium can become resistant. It is a "name" command, so only the names of the mechanisms are required — no description or explanation.

Approach

Recall the two overarching routes by which resistance arises: a change within the bacterium's own genome, or acquisition of a gene from outside. Give one example of each.

Step-by-Step Reasoning

• Mark 1: mutation. State that resistance can arise by a (random) mutation in the bacterial DNA that changes an antibiotic target or otherwise confers resistance.
• Mark 2: horizontal gene transfer. Name any one of conjugation, transformation or transduction — or simply write "horizontal transmission / horizontal gene transfer."

Key Takeaways

• Mutation and HGT are the two routes by which bacterial resistance originates.
• HGT is what makes resistance spread so rapidly between species.

Common Mistakes

• Confusing "mutation" with "adaptation" — bacteria do not mutate deliberately in response to the antibiotic; the mutation is random and pre-dates the exposure.
• Naming antibiotic-target modification as a separate mechanism — it is a consequence of mutation, not a separate route.

Things to Be Careful About

Either one of conjugation, transformation or transduction earns the mark; candidates need not list all three.

Background Concept

Whole-genome sequencing (and targeted sequencing of resistance genes) is now routine in public-health microbiology. By comparing bacterial genomes from different patients, hospitals, countries and time-points, scientists can:

• identify which mutations or resistance genes are appearing;
• track how resistant strains are spreading geographically;
• detect the emergence of novel resistance mechanisms early;
• inform prescribing policy and the development of new antibiotics.

Understanding the Question

The command word is "suggest" — only one mark, so a single, well-focused point is needed. The candidate must link WHO's DNA-sequence analysis to solving the resistance problem, not merely describing what sequencing is.

Approach

Think about what useful information sequence data uniquely provides, then translate that into an action that helps tackle resistance.

Step-by-Step Reasoning

• Sequencing identifies resistance mutations / resistance alleles (mark-scheme option 1).
• Once known, those mutations/genes can be tracked between strains, patients and regions, showing how resistance is spreading.
• Alternatively, the information can guide (informed) choice of antibiotic in clinical settings, or the development/production of new antibiotics targeting emerging resistant strains (mark-scheme option 3).
  Any one of these links earns the mark.

Key Takeaways

• Genomic surveillance is a key modern tool for managing antibiotic resistance.
• The mark scheme accepts any one of: tracking resistance, identifying mechanisms, or informing antibiotic choice/production.

Common Mistakes

• Vague answers such as "to identify resistant bacteria" — too imprecise; credit requires reference to mutations, genes or alleles.
• "To cure resistant infections" — sequencing does not directly cure disease.

Things to Be Careful About

The word "suggest" invites an idea, but the answer must be biologically specific (mutations / resistance genes / choice of antibiotic) to score.

Background Concept

Natural selection requires three ingredients:

1. Variation in a population (here, some bacteria carry a resistance allele, most do not).
2. A selection pressure — an environmental factor that differentially affects survival/reproduction (here, streptomycin).
3. Differential survival and reproduction of the better-adapted variants, so the favoured alleles are passed on and increase in frequency over generations.

Because the environment (presence of streptomycin) favours one extreme of the variation (the resistant phenotype), this is a classic case of directional selection — the population's allele frequencies shift in one direction.

Understanding the Question

The stem tells us streptomycin is the antibiotic and that an incomplete course makes resistance "more likely to develop." The candidate must explain the mechanism by which incomplete dosing promotes the evolution of resistance through natural selection. The command word "explain" demands reasoning, not just definitions: each point should make clear why, not just what.

Approach

Work through the stages of natural selection in order: identify the selection pressure, state the variation, explain the differential survival, and name the type of selection. Bring in the incomplete-course detail to explain why resistance is more likely in that situation.

Step-by-Step Reasoning

1. Streptomycin is the selection pressure (mark-scheme point 1). It kills or inhibits the growth of susceptible bacteria, so only bacteria that can tolerate it survive.

2. Resistant bacteria survive and reproduce; susceptible ones do not (mark-scheme point 2). Within any large bacterial population a few individuals already carry a resistance allele (from earlier mutation or HGT). Under streptomycin exposure these have a selective advantage and so leave more offspring than non-resistant bacteria — or reverse argument (ORA): non-resistant bacteria are killed.

3. The resistance allele is inherited by the offspring (mark-scheme point 3). Bacteria reproduce asexually by binary fission, so each daughter cell inherits a complete copy of the parental genome including the resistance allele; resistance can also spread sideways by HGT.

4. Result: directional selection (mark-scheme point 4). Over successive generations the proportion of resistant bacteria in the population rises — the population's allele frequency has shifted in one direction.

Why does an incomplete course make this worse?
If a patient stops taking streptomycin before all the bacteria are eradicated, two things follow:

• A sub-lethal concentration of antibiotic remains in the body for a time.
• Some bacteria (perhaps already weakened but still alive) are exposed to the drug at a concentration high enough to select for resistance but not high enough to eliminate all resistant cells. Sensitive bacteria are killed off, leaving resistant ones to multiply.
• A higher proportion of the bacteria that repopulate the body therefore carry the resistance allele, and these may be passed to others — spreading the resistant strain.

Key Takeaways

• Antibiotic resistance evolves by the same natural-selection mechanism as any other adaptation.
• The key elements to credit are: selection pressure, differential survival, inheritance of the resistance allele, and directional selection.
• Incomplete antibiotic courses create conditions that favour the survival of partially-resistant cells, increasing the chance that a resistant strain emerges.

Common Mistakes

• Stating that the antibiotic causes the mutation — it does not; mutations arise randomly, the antibiotic merely selects existing variants.
• Saying bacteria "become immune" — bacteria are not immune in the immunological sense; the correct term is "resistant."
• Omitting the inheritance step — the allele must be passed on for evolution to occur.
• Not naming the type of selection (directional).

Things to Be Careful About

• "Explain" requires the reason behind each statement; simply listing terms does not earn full marks.
• Either "allele" or "gene" is acceptable in the inheritance point; the mark scheme uses both.
• A reverse argument (ORA) — sensitive bacteria die — is accepted as an alternative way to make the differential-survival point.

Background Concept

The polymerase chain reaction (PCR) is a cyclical, in-vitro method for amplifying a specific region of DNA. Each cycle has three temperature-controlled steps:

1. Denaturation (~95 °C): the double-stranded DNA template is heated to break the hydrogen bonds between complementary bases, giving two single strands.
2. Annealing (~55 °C): short single-stranded DNA primers bind (anneal) to the complementary sequences flanking the target region on each template strand.
3. Extension (~72 °C): a DNA polymerase adds free deoxyribonucleotides (dNTPs) to the 3′ end of each primer, building a new complementary strand.

A thermostable DNA polymerase is essential because the reaction is repeatedly heated to ~95 °C during denaturation. Taq polymerase, isolated from the thermophilic bacterium Thermus aquaticus, tolerates this temperature without denaturing.

Understanding the Question

The stem of Question 5 already states that genomic DNA and primers are added to the PCR machine. Part (a) asks for two further substances that must be added, together with a reason for each. Marks are awarded in pairs — name + explanation — so the answer must contain both a correct reagent and a correct role for that reagent. A buffer is an acceptable third option but is not essential for full marks.

Approach

Identify the components that the polymerase needs to do its job:

• a supply of building blocks (dNTPs) to extend the primers;
• a working catalyst that survives the cycling temperatures (Taq polymerase);
• a stable chemical environment (buffer).

For each, give the biological reason, not just a vague description.

Step-by-Step Reasoning

Pair 1 — dNTPs:
The new complementary strand is built by joining free nucleotides one at a time to the 3′-OH of the primer. Each dNTP must base-pair with the corresponding template base (A with T, C with G). Without dNTPs there are no building blocks. The mark requires the idea of annealing to complementary bases, not just "to build DNA".

Pair 2 — Taq polymerase:
Two mark-worthy explanations are accepted:

1. It catalyses the formation of phosphodiester bonds that join nucleotides into a new sugar–phosphate backbone (i.e. it builds the complementary strand).
2. It is thermostable / does not denature at the high temperatures (~95 °C) used in the denaturation step — a property ordinary DNA polymerase does not have.

Either (or both) earns the explanation mark.

(Optional third pair — buffer: provides the optimum/suitable/constant pH for the polymerase to work, or prevents denaturation of the enzyme/damage to DNA.)

Key Takeaways

• The four essentials of a PCR mixture are: template DNA, primers, dNTPs and a thermostable DNA polymerase (Taq), normally in a buffer with Mg²⁺.
• Each component has a specific, named function; vague answers such as "for the reaction to work" do not score.
• The high temperature used in PCR is the reason a thermophilic enzyme is required.

Common Mistakes

• Naming "nucleotides" without specifying deoxyribonucleotides / dNTPs — the mark scheme requires the precise term.
• Giving a role that belongs to the primers (e.g. "dNTPs bind to the template") rather than the role of dNTPs themselves.
• Saying polymerase "denatures the DNA" — denaturation is done by the high temperature, not by the enzyme.
• Stating Mg²⁺ as a substance — it is normally present in the buffer, so naming the buffer is more standard.

Things to Be Careful About

• Marks are paired: a correct reagent with a wrong explanation scores only the explanation mark (or vice versa). Make sure each name is matched with its correct role.
• "Provides energy" is a frequent wrong claim for dNTPs — energy comes from the high-energy phosphates of the dNTPs themselves, but that is not the answer's required function.
• "Heat-stable enzyme" alone, without saying why that matters (the high denaturation temperature), is too vague.

Background Concept

PCR is an exponential amplification: at the end of each cycle, every double-stranded DNA molecule has been duplicated, so the number of copies doubles. Starting from a single molecule:

• after 1 cycle → 2 copies
• after 2 cycles → 4 copies
• after n cycles → $2^n$ copies

After ~30 cycles a single molecule is amplified to over a billion — this is what makes PCR powerful enough to detect DNA from a single cell.

Understanding the Question

The stem fixes the starting amount at 1 copy and the number of cycles at 35. The candidate must:

1. Compute $2^{35}$.
2. Express it in standard form (i.e. as $a \times 10^n$ where $1 \leq a < 10$).
3. Round to two significant figures.

Approach

Calculate $2^{35}$ exactly, then rewrite the integer in scientific notation and round to two sig figs.

Step-by-Step Reasoning

The first non-zero digit is 3, so the standard form places the decimal after the 3:

To two significant figures, look at the third sig fig (3) and round the second (4) down (because 3 < 5):

Key Takeaways

• PCR amplification follows the formula $\text{copies} = 2^n$ when starting from one molecule.
• Standard form requires the mantissa to be in the range $[1, 10)$.
• "Two significant figures" means two digits in the mantissa (here 3 and 4), with the rest rounded off.

Common Mistakes

• Writing the answer as $3.4 \times 10^{9}$ — this is off by a factor of 10 (a common slip when counting the powers).
• Writing $34 \times 10^{9}$ — not in standard form (mantissa ≥ 10).
• Giving $3.44 \times 10^{10}$ — three significant figures, not two.
• Stating $2^{35} = 35^2$ — confusing the formula with the wrong arrangement.

Things to Be Careful About

• $2^{10} = 1024 \approx 10^3$ is a useful mental check: $2^{35} \approx 2^{30} \times 2^{5} \approx 10^9 \times 32 \approx 3 \times 10^{10}$, consistent with the answer.
• The mark is awarded for the final numerical value; the working shown above is good practice but the answer line is the only thing that scores. Make sure $3.4 \times 10^{10}$ is clearly written on the answer line.

Background Concept

Neonatal screening is a public-health programme in which newborn babies are tested for certain genetic or metabolic conditions that benefit from very early intervention (the classic UK example is the heel-prick test for phenylketonuria, PKU). Decisions about whether to add a condition to a screening programme are usually judged against the Wilson and Jungner criteria, which include:

• the condition is an important health problem;
• there is an accepted treatment;
• facilities for diagnosis and treatment are available;
• the test is suitable and acceptable;
• the cost of case-finding is balanced against the benefit.

MLD fits several of these well (important health problem, treatment now exists) but fails others (cost, uncertain long-term outcome). The discussion in this question is therefore genuinely balanced.

MLD itself is caused by mutations in the ARSA gene (chromosome 22), inherited in an autosomal recessive pattern. Both parents of an affected child are typically unaffected carriers — there is often no family history of the disease.

Understanding the Question

The stem supplies four pieces of background:

1. MLD is autosomal recessive, very rare (1 in 40 000 births), with reduced life expectancy.
2. It causes severe disability and previously had no cure.
3. A new gene therapy (Libmeldy®) is available from 2022, but only works if given before symptoms appear and is extremely expensive.
4. Most countries already perform neonatal screening for other diseases using the same blood sample.

The candidate is asked to discuss the social and ethical considerations of adding MLD to that screening programme, assuming gene therapy is available in the country. "Discuss" demands a balanced argument with points on both sides, not a one-sided essay.

Approach

Structure the argument around three questions:

1. Who benefits? (the child, the family, society)
2. At what cost? (financial, psychological, medical)
3. With what certainty? (test accuracy, long-term outcome of treatment)

For each, give at least one mark-worthy point on each side where possible, and aim to use the information supplied in the stem.

Step-by-Step Reasoning

Argument 1 — MLD can affect children with no family history. Because MLD is autosomal recessive, two unaffected carrier parents can have an affected child. Screening therefore identifies cases that would otherwise be missed — a positive social argument for inclusion. (mark point 1)

Argument 2 — Early detection is essential for treatment to work. Libmeldy® must be given before symptoms appear. Without screening, the diagnosis would normally be made only after irreversible neurological damage has occurred, by which time the therapy is useless. Screening therefore directly enables curative treatment. (mark point 2)

Argument 3 — Improved outcome. Early treatment can greatly improve the child's quality of life and life expectancy, transforming a fatal childhood disease into a survivable one. (mark point 3)

Argument 4 — Family planning. A positive neonatal screen alerts the family and extended relatives (who may also be carriers) to the risk in future pregnancies. They can be offered genetic counselling and prenatal testing in subsequent pregnancies. (mark point 4)

Argument 5 — No extra sampling. Neonatal screening is performed on a blood sample already taken for other tests; adding MLD adds no further invasive procedure for the baby. (mark point 5)

Argument 6 — Cost of screening. Screening an entire newborn population for a disease affecting only 1 in 40 000 is expensive per case detected. Healthcare budgets are finite; money spent on MLD screening is not available for other services. (mark point 6)

Argument 7 — Cost of treatment. Even if a baby is screened positive, the gene therapy itself is described as extremely expensive — likely beyond the reach of most families without state funding, raising issues of equity of access. (mark point 7)

Argument 8 — Test accuracy. No screening test is perfect; false positives cause unnecessary anxiety and possibly unnecessary treatment, false negatives give false reassurance. (mark point 8)

Argument 9 — Unknown long-term effects of the gene therapy. The treatment only became available in 2022; its long-term safety and durability of cure are not yet established. Committing a child to a novel therapy carries unknown risks. (mark point 9)

Any four of these nine points, with a sensible mix of for-and-against, earns full marks. The strongest answers explicitly link each point back to the information in the stem (autosomal recessive, treatment must be early, expensive, 2022) and to a named ethical principle (autonomy, justice, non-maleficence, equity).

Key Takeaways

• "Discuss" means present both sides, not just the advantages.
• Use the stem's information: autosomal recessive (no family history needed), gene therapy only works if early, very expensive.
• Common ethical principles to deploy: autonomy (parental choice), beneficence (improving the child's life), non-maleficence (avoid harm from inaccurate tests or unknown treatment effects), justice (fair allocation of healthcare resources).
• A strong conclusion states a defensible position; a weak conclusion merely summarises both sides without taking a view.

Common Mistakes

• Writing a one-sided essay that only lists benefits — this caps the mark even if the points are correct.
• Repeating the same idea in different words (e.g. "early treatment is good" + "treatment before symptoms helps") instead of giving distinct points.
• Forgetting that the question specifies "in a country where gene therapy for MLD is available" — the treatment-cost point is therefore about who pays for an existing therapy, not about whether the therapy exists.
• Confusing screening with diagnosis: screening identifies likely cases in a healthy population; diagnosis confirms the disease in a person with symptoms or a positive screen.

Things to Be Careful About

• Watch the wording: "social and ethical considerations" is broader than "medical considerations" — include family, equity and resource-allocation arguments, not just clinical ones.
• Connect each ethical point to the specific facts in the stem (rarity, recessiveness, cost, novelty of treatment). Generic ethics points ("it is right to save lives") do not score.
• Marks are awarded for any four distinct, well-justified points; aim to give five or six to be safe.

Background Concept

Insulin is the hormone that lowers blood glucose concentration after a meal. It does not enter muscle or adipose cells; instead it binds to a specific tyrosine-kinase receptor on the cell surface membrane. This binding triggers an intracellular cascade of enzymes — in this question, PI3K (phosphoinositide 3-kinase) and PKB (protein kinase B, also called Akt). The end-point of the cascade is the insertion of GLUT4 glucose transporter proteins into the cell surface membrane. GLUT4 is stored in vesicles inside the cytoplasm; when insulin signals, these vesicles fuse with the membrane so that glucose can enter the cell down its concentration gradient by facilitated diffusion. In liver and pancreatic β-cells other transporters (GLUT2) are always present, but in muscle and fat cells GLUT4 is insulin-dependent, so the cell-signalling cascade controls how much glucose these tissues take up.

Type 2 diabetes mellitus is a disorder in which target cells become resistant to insulin, or in which the signalling cascade downstream of the insulin receptor is defective. The result is that blood glucose cannot be cleared efficiently into muscle, liver and adipose tissue, so it remains elevated (chronic hyperglycaemia).

Understanding the Question

This is a "suggest" question worth 4 marks. You are given Fig. 6.1, which is a simplified diagram of the cascade:
insulin → receptor → PI3K → PKB → vesicle (with GLUT4) → vesicle fuses with cell surface membrane → glucose enters cell.

The stem tells you that some people with type 2 diabetes have a low concentration of PI3K. You must use Fig. 6.1 to work out the chain of consequences: what happens downstream of PI3K when PI3K is scarce, and how that links back to a high blood glucose concentration.

The command word "suggest" means you are being asked to apply the pathway to an unfamiliar scenario — you are not just describing normal insulin action, you are explaining the consequences of removing a step.

Approach

Read the diagram in the direction the arrows point. PI3K sits between the insulin receptor and PKB. If PI3K is reduced, every step after it is reduced. Walk down the chain — PKB activation, vesicle movement/fusion, GLUT4 insertion, glucose entry, blood glucose level — and write each step as a separate marking point. End with the final physiological consequence (blood glucose remains high), because that is what defines diabetes.

Step-by-Step Reasoning

1. PI3K activates PKB. Fig. 6.1 shows the arrow from PI3K to PKB with the label "activation". If there is less PI3K, less PKB is activated. (Marking point 1.)
2. PKB normally triggers vesicle movement. The diagram shows the arrow from PKB to the vesicle. With less active PKB, fewer vesicles are triggered to move to and fuse with the cell surface membrane. (Marking point 2.)
3. GLUT4 must reach the membrane. The vesicles carry GLUT4 transporters. If fewer vesicles fuse, fewer GLUT4 proteins are inserted into the cell surface membrane, and the membrane is less permeable to glucose. (Marking point 3 — note the mark scheme accepts either fewer GLUT4 added to the membrane, or the membrane being less/not permeable to glucose.)
4. Glucose entry is reduced. Glucose can only enter the muscle cell by facilitated diffusion through GLUT4. With fewer transporters, less glucose is taken up. (Marking point 4.)
5. Blood glucose remains high. Because muscle is a major site of glucose disposal, blood glucose is not cleared from the blood and remains higher than normal. (Marking point 5 — note the mark scheme says "blood" specifically; do not just say "glucose concentration".)

Key Takeaways

• Insulin acts through a cell-signalling cascade; the response is amplified at each step, so loss of one enzyme has a disproportionate effect on the whole pathway.
• The key end-point of insulin in muscle and fat cells is the insertion of GLUT4 into the cell surface membrane.
• In a "suggest" question on a pathway, walk step by step from the missing/defective component to the final physiological outcome, and make each step a separate mark.

Common Mistakes

• Saying "insulin cannot bind to its receptor" — the question states that insulin signalling begins normally; the problem is downstream (PI3K is low). The receptor step is unaffected.
• Saying "glucose cannot enter the cell" without naming facilitated diffusion / GLUT4. The mark scheme credits the mechanism, not just the outcome.
• Writing "glucose concentration is high" instead of "blood glucose concentration is high" — the qualifier matters because the disease is defined by the blood concentration, not the intracellular one.
• Missing the chain — for example, jumping straight from "less PI3K" to "high blood glucose" without the intermediate steps (PKB, vesicle, GLUT4). Each of those intermediates is its own mark.

Things to Be Careful About

• The mark scheme rewards quantitative/comparative wording: "less / no", "fewer / no", "remains higher". Avoid absolute statements like "PKB is inactive" if you mean "less PKB is activated" — the cascade is not all-or-nothing.
• The membrane is not "impermeable" to glucose in absolute terms; it simply has fewer GLUT4 channels. The correct wording is "less permeable" or "not as permeable".
• The mark scheme requires the word "blood" before "glucose concentration" in the final point.

Background Concept

A biosensor is an analytical device that combines a biological recognition element (an enzyme, antibody, or whole cell) with a physical transducer that converts the biological signal into a measurable electrical one. The biological element binds or reacts with the analyte (the substance being measured) very specifically, and the transducer turns that interaction into a current, voltage, or other signal that can be quantified.

A blood glucose biosensor exploits the enzyme glucose oxidase, which is highly specific for β-D-glucose. The overall reaction is:

The hydrogen peroxide produced can be detected electrochemically — at an electrode it is oxidised, releasing electrons. The current that flows is proportional to how much H₂O₂ (and therefore how much glucose) was present in the original sample.

Biosensors are widely used by people with diabetes for self-monitoring, because they are portable, give a numerical reading, and produce a result in seconds from a tiny drop of capillary blood.

Understanding the Question

This is a 7-mark "describe" question. You are asked to give a structured account of how a biosensor measures blood glucose. The mark scheme lists ten separate credit-worthy points and asks for any seven, so you need to cover the major stages of the process: the recognition element, sample introduction, selective membrane, enzyme reaction, transducer, amplification, and quantitative readout.

A "describe" question rewards a logical sequence of clearly stated points rather than a single long paragraph. Use a numbered or bulleted layout that mirrors the order in which events happen in the device.

Approach

Think of the biosensor as a pipeline that turns glucose concentration into a digital number:

1. Recognition layer — what biological molecule captures the analyte (glucose oxidase).
2. Sample handling — how the blood is introduced and how glucose reaches the enzyme (partially permeable membrane).
3. Enzyme reaction — what the enzyme does (oxidises glucose; products = gluconic acid + H₂O₂).
4. Transduction — how the chemical change becomes an electrical signal (electrode produces a current).
5. Signal processing and display — amplification and a digital read-out, with the current proportional to concentration.

A useful mnemonic is R-SET-A-D: Recognition, Sample/SElective membrane, Enzymatic reaction, Transduction, Amplification, Digital display.

Step-by-Step Reasoning

• Recognition layer (point 1). The biosensor contains glucose oxidase, immobilised on a recognition layer. This is the biological component that gives the device its specificity for glucose.
• Sample addition (point 2). A small volume of capillary blood is placed on the biosensor.
• Selective membrane (point 3). Glucose must reach the immobilised enzyme. Other blood components (red cells, proteins) are excluded by a partially / selectively permeable membrane that lets small molecules like glucose through but keeps out larger components. This protects the enzyme and prevents interference.
• Enzyme reaction (points 4–5). Glucose oxidase catalyses the oxidation of glucose. The two products are gluconic acid and hydrogen peroxide (H₂O₂). The mark scheme rewards naming both products.
• Transduction (point 6). A transducer (electrode) detects the products and converts the chemical signal into an electrical current.
• Amplification (point 7). The current is very small, so it is amplified before being read.
• Display (points 8–9). The amplified current is shown on a digital / numerical display as a quantitative value. The size of the current is proportional to the glucose concentration — this is the key relationship that allows the device to give a true concentration reading rather than just a yes/no answer.
• Advantages (point 10). The result is instant (seconds) and accurate / quantitative (an actual number, not just a colour comparison like a urine dipstick or older test strip).

Key Takeaways

• A biosensor has three essential parts: a biological recognition element (glucose oxidase), a transducer (electrode producing a current), and a display (digital readout).
• The reaction catalysed by glucose oxidase is the chemical basis: glucose + O₂ → gluconic acid + H₂O₂.
• Quantitative output (a number, not a colour) and the proportionality between signal and analyte concentration are what distinguish a biosensor from a simple test strip.

Common Mistakes

• Writing only "an enzyme is used" without naming glucose oxidase. The mark scheme requires the specific enzyme.
• Omitting the partially permeable membrane — students often describe the device as if the blood simply contacts the enzyme directly.
• Naming only one of the two products (gluconic acid and hydrogen peroxide are both required).
• Confusing the biosensor with a urine test strip (e.g. mentioning a colour change compared with a chart). The mark scheme rejects the colour/comparison approach because biosensors give a digital, current-based reading.
• Forgetting the amplifier, or forgetting to say that current is proportional to glucose concentration.

Things to Be Careful About

• "Describe" questions on biosensors always expect the order of events as well as the named components. Lay the points out in the sequence in which the sample encounters each part of the device.
• Use the precise term transducer for the component that converts chemical signal to electrical signal.
• Use digital / numerical / quantitative to describe the readout — avoid "analogue", "colour" or "visual".
• The mark scheme says "any seven from ten"; aim to make seven clear, distinct points rather than padding a few points with extra words. Each numbered point above is independent and credit-worthy.

Background Concept

An action potential is a brief, all-or-nothing depolarisation of the membrane that travels along a neurone. It is followed by an absolute refractory period — during which voltage-gated Na⁺ channels are inactivated and no stimulus, however strong, can trigger another action potential — and a relative refractory period — during which a stronger-than-normal stimulus is needed to reach threshold because some Na⁺ channels are still inactivated and K⁺ channels are still open.

Together, these two phases constitute the refractory period. The refractory period is not just an unavoidable consequence of ion-channel kinetics — it is essential to how a nerve impulse is shaped.

Understanding the Question

You are told that Venus fly traps produce action potentials with a refractory period similar to those in mammalian neurones. You must EXPLAIN the role of the refractory period in the transmission of a nerve impulse in a mammalian neurone. Three marks are available, so three linked points are expected.

Approach

Think of the refractory period as a brief "dead zone" in the membrane behind the action potential. Ask yourself what consequences this dead zone has for the shape, direction and frequency of the impulse. The three consequences the mark scheme rewards are: (1) discreteness, (2) unidirectionality and (3) frequency limitation.

Step-by-Step Reasoning

Point 1 — discreteness of impulses.
During the refractory period the Na⁺ channels cannot reopen. This means a second action potential cannot be triggered on top of the first — they cannot summate or merge. Each impulse therefore remains a discrete, separate event with a clear beginning and end.

Point 2 — unidirectionality of impulses.
The membrane immediately behind the advancing action potential is in its refractory period. Even if a stimulus reached that region, it could not re-excite it. The action potential can therefore only move on into the next region of resting membrane ahead of it. This forces the impulse to travel in one direction only along the axon, from the receptor (or cell body) towards the synapse.

Point 3 — frequency limit.
Because the membrane cannot fire again until the refractory period is over, there is a minimum time interval between successive action potentials. In a mammalian motor neurone this gives a maximum firing rate of a few hundred impulses per second (the AVP mark-scheme example is "200–300 action potentials per second"). The refractory period therefore sets an upper limit on how often a neurone can signal — important because frequency of impulses encodes stimulus intensity.

Key Takeaways

The refractory period is not just a recovery phase — it is the reason nerve impulses are single, all-or-nothing pulses that march in one direction only along an axon and that cannot occur faster than a maximum frequency. Without the refractory period, impulses would merge, travel in both directions, and the frequency code would collapse.

Common Mistakes

• Saying "the neurone rests" — the refractory period is not rest; it is an active, ion-channel-mediated state.
• Saying only "limits frequency" without explaining why (must connect frequency limit to the inability to re-stimulate the membrane during the refractory period).
• Confusing absolute and relative refractory periods, or omitting the fact that the absolute refractory period is what enforces unidirectionality.
• Drifting into describing the phases of an action potential rather than the FUNCTION of the refractory period — the question asks for the role, not the events.

Things to Be Careful About

The mark scheme rewards any three of the points above. To be safe, aim to cover all three (discreteness, unidirectionality, frequency limit). The "unidirectional" point is the most commonly missed — make the link between "the region behind is refractory" and "impulse cannot go backwards" explicit.

Background Concept

Conservation of an endangered species requires actions that address the immediate threats (in this case, habitat loss from deforestation for oil-palm plantations and possible hunting/trade) and that maintain or rebuild populations. Strategies fall into two broad groups: in-situ conservation (protecting the species where it naturally lives) and ex-situ conservation (removing individuals from the wild to breed or safeguard them). Legislation, education, and research underpin both approaches.

Understanding the Question

The stem tells us that the Bornean orangutan (Pongo pygmaeus) is critically endangered because tropical rainforest on Borneo is being cleared for oil-palm plantations. The command word is "suggest", so the examiner will accept any reasonable, biologically sensible conservation measure — but each must be a distinct point and clearly linked to the orangutan's situation (e.g. it would not be sensible to suggest "seed banks", which are a plant-conservation measure).

Approach

Read the mark scheme's eight creditable points and select the four that best fit the orangutan case. Try to choose a mix of in-situ and ex-situ approaches, plus legislative and social ones, because the question gives four marks and the examiner is looking for breadth.

Step-by-Step Reasoning

1. Protected reserves (e.g. national parks, IUCN Category I–IV areas) prevent logging and plantation expansion within defined areas of rainforest, so orangutans continue to have suitable habitat. The mark scheme explicitly accepts "named" reserves, so an example such as "Bornean Orangutan Sanctuary" is fine.
2. Limit palm oil plantations / use sustainable palm oil directly addresses the named threat in the stem. Certification schemes (e.g. RSPO) reduce the rate of forest conversion.
3. Restoring lost habitat / reforestation rebuilds forest that has already been cleared, eventually re-connecting fragmented populations and allowing population sizes to increase.
4. Captive breeding programmes maintain a safety-net population in zoos/sanctuaries and can supply individuals for release.
5. Release into the wild (a follow-up to captive breeding) re-establishes or augments wild populations. This and the previous point are paired in the mark scheme, so if both are written they are credited.
6. Ban hunting / trade removes a direct source of mortality. International trade is controlled under CITES, and orangutans are listed on Appendix I, which prohibits commercial trade.
7. Raise awareness / education changes consumer behaviour (e.g. choosing sustainable palm oil) and reduces demand for illegal pet trade.
8. Research into population size, distribution, genetics and ecology is essential for designing and monitoring the other measures.

Any four of these are worth one mark each.

Key Takeaways

• Conservation has in-situ and ex-situ components; both are needed for critically endangered species.
• The best answers tailor the measure to the named threat — here, deforestation for oil palm is the headline pressure, so habitat-based and palm-oil-specific actions are particularly apt.
• Legislation (bans, protected-area designation) and socio-economic measures (education, certification) are equally part of conservation.

Common Mistakes

• Suggesting seed banks or frozen zoos for an animal — these are appropriate for plants or for genetic material, not for a mammal like the orangutan.
• Vague answers like "look after them better" or "stop pollution" — too general to credit.
• Repeating the same idea twice in different words — e.g. "ban hunting" and "stop killing orangutans" earn only one mark.

Things to Be Careful About

• "Suggest" questions have many acceptable answers, but each answer must be a specific, distinct measure. Generic statements such as "conserve them" score nothing.
• Where the mark scheme uses "R" or "reject" annotations elsewhere, "R" is not present here, but be aware that the mark scheme caps this question at four marks even though eight points are listed — only the best four need to be offered.

Background Concept

Biodiversity is a multi-level concept: it is not just "how many species are there?" but also "how different are the habitats?" and "how varied are the genes inside a single species?" The Cambridge syllabus treats these as three nested, complementary levels.

Understanding the Question

The command word is "outline", which means a short description of each level is enough — one sentence or a tight bullet per level. Three marks means the examiner expects three distinct points, one for each level.

Approach

Recall the three levels in order from the broadest (ecosystem) to the most specific (genetic) and give a short defining phrase for each.

Step-by-Step Reasoning

1. Ecosystem (habitat) diversity — the variety of different ecosystems or habitats in a given area (e.g. rainforest, mangrove, peat-swamp, riverine). A region with many habitat types is more biodiverse at this level than one with only a single habitat.
2. Species diversity (richness) — the number of different species in an area and their relative abundance. This is the level usually meant when a non-specialist talks about "biodiversity".
3. Genetic diversity — the variety of alleles and genotypes within a single species (or a single population). High genetic diversity gives a species more raw material for evolution and a better chance of surviving environmental change.

Key Takeaways

• Biodiversity has three levels: ecosystem, species, genetic.
• Loss can happen at any of the three: habitat destruction (ecosystem), local extinction (species), and inbreeding / population bottlenecks (genetic).

Common Mistakes

• Listing "plants and animals" or "flora and fauna" as levels — these are groups of organisms, not levels of biodiversity.
• Confusing species richness with species evenness — the two together make up species diversity, but the level itself is just "species diversity".
• Writing only two of the three levels and splitting the third into two points — only three marks are available, so a fourth point scores nothing.

Things to Be Careful About

• "Outline" does not require a long essay; a one-line definition of each level is enough.
• Make sure the genetic-level point is about within-species variation, not about variation between species (that is species diversity).

Background Concept

Neurones transmit electrical signals (action potentials) along their length. In an unmyelinated axon the action potential must be regenerated at every point along the membrane — voltage-gated Na⁺ channels open, Na⁺ floods in, the membrane reverses polarity, K⁺ then leaves, and the cycle repeats a micrometre further along. This is continuous conduction and is relatively slow because the local circuits of passive depolarisation are very short.

In a myelinated axon, Schwann cells wrap tightly around the axon, leaving only the nodes of Ranvier exposed. Myelin is lipid-rich and acts as an excellent electrical insulator: ions cannot cross the membrane in the wrapped regions, and the membrane capacitance is dramatically reduced. The action potential therefore cannot be regenerated in the myelinated stretches; it can only be regenerated at the nodes, where the membrane is bare and densely packed with voltage-gated Na⁺ channels.

Understanding the Question

The stem sets a myelinated motor neurone conducting at up to $100\ \text{m s}^{-1}$ and asks for an outline of how this speed is achieved. The command word "outline" means a short, structured description of the main features, not an essay. Three marks means three distinct creditable points. The figure $100\ \text{m s}^{-1}$ is signalling that the answer is about saltatory conduction rather than about the action potential itself.

Approach

Reach for the concept of saltatory conduction. State that myelin insulates, that depolarisation is restricted to the nodes, and that the action potential therefore "jumps" from node to node. The mark scheme additionally credits longer local circuits and a wide axon diameter as alternative points (AVP).

Step-by-Step Reasoning

• The myelin sheath is formed by Schwann cells wrapped concentrically around the axon. Its lipid-rich membranes act as an electrical insulator, so ions cannot flow across the membrane in the wrapped regions.
• Because no ion movement is possible through myelin, depolarisation and the action potential can only be regenerated at the nodes of Ranvier, where the axon membrane is exposed and densely packed with voltage-gated Na⁺ channels.
• The action potential therefore effectively "jumps" from one node to the next — this is saltatory conduction (from the Latin saltare, to leap).
• Between nodes, depolarisation spreads passively as a local circuit. In a myelinated axon these local circuits are much longer than in an unmyelinated axon (myelin reduces capacitance and increases the length constant), so the impulse effectively leaps long distances without continuous regeneration.
• (AVP) A wider axon diameter also increases conduction velocity because internal longitudinal resistance to ion flow is lower. This is an acceptable extra marking point.

Key Takeaways

• Myelin = insulation; nodes = the only sites of action potential regeneration.
• Saltatory conduction = action potentials jumping from node to node.
• Faster than continuous conduction because local circuits are long.
• Wider axons also help.

Common Mistakes

• Stating that "the myelin sheath speeds up the impulse" — myelin does not change the local speed of the action potential itself; it allows the impulse to skip ahead in larger jumps.
• Confusing the nodes of Ranvier with synapses — they are gaps in the myelin on the same neurone, not connections between neurones.
• Stating that impulses "jump" without explaining that they must be regenerated at each node.

Things to Be Careful About

• The mark scheme explicitly rejects the word "impulses" for point 2 — use "depolarisation" or "action potential".
• The mark scheme offers an AVP slot, so a correct additional point (e.g. wide axon diameter) is also acceptable for one of the three marks.

Background Concept

The neuromuscular junction (NMJ) is the synapse between a motor neurone and a skeletal muscle fibre. The motor neurone's axon terminal sits in a shallow trough on the muscle surface, separated from the sarcolemma by a narrow synaptic cleft. When an action potential reaches the terminal, voltage-gated Ca²⁺ channels in the presynaptic membrane open, Ca²⁺ enters, and vesicles of acetylcholine (ACh) fuse with the presynaptic membrane, releasing ACh into the cleft. ACh then diffuses across the cleft and binds to nicotinic receptors on the sarcolemma.

The sarcolemma is not a flat sheet — it has deep invaginations called transverse tubules (T-tubules) that run into the interior of the muscle fibre. Wrapped around the myofibrils is a network of modified endoplasmic reticulum called the sarcoplasmic reticulum (SR), which is the Ca²⁺ store of the muscle cell. The T-tubules lie very close to the SR, so that an electrical signal reaching the T-tubule can rapidly open voltage-gated Ca²⁺ channels on the adjacent SR membrane.

Excitation-contraction coupling is the term for the chain of events that links an action potential in the sarcolemma to the release of Ca²⁺ around the myofibrils, and ultimately to the binding of that Ca²⁺ to troponin on the actin filaments.

Understanding the Question

The stem reminds you that ACh is released and diffuses to the sarcolemma. The command word is "describe", asking you to trace the chain from ACh binding on the sarcolemma through to Ca²⁺ release from the SR and its binding to troponin. Four marks means four distinct creditable points (the mark scheme offers six, of which any four are credited).

Approach

Work step by step through excitation-contraction coupling: ACh receptor → Na⁺ entry → depolarisation → T-tubules → voltage-gated Ca²⁺ channels on the SR → Ca²⁺ release → troponin binding. Use the precise terms (ligand-gated, voltage-gated, sarcolemma, T-tubules, sarcoplasmic reticulum) because each is a marking point.

Step-by-Step Reasoning

• ACh diffuses across the synaptic cleft and binds to receptors on the sarcolemma. The receptors are nicotinic, ligand-gated Na⁺ channels.
• Binding of ACh opens the channels; Na⁺ flows into the muscle cell down its electrochemical gradient. This depolarises the sarcolemma, producing an end-plate potential that triggers an action potential in the adjacent membrane.
• The action potential spreads across the surface of the sarcolemma and is carried deep into the fibre by the T-tubules, which are continuous with the sarcolemma.
• The depolarisation of the T-tubule membrane activates voltage-gated Ca²⁺ channels (dihydropyridine receptors coupled to ryanodine receptors) on the membrane of the sarcoplasmic reticulum. Note: the trigger for these channels is the voltage change, not extracellular Ca²⁺.
• Ca²⁺ stored in the SR at very high concentration flows out into the sarcoplasm down its concentration gradient.
• The Ca²⁺ diffuses to the thin filaments and binds to troponin, changing its shape and pulling tropomyosin away from the myosin-binding sites on actin.

Key Takeaways

• ACh → Na⁺ entry → depolarisation → T-tubule → voltage-gated Ca²⁺ channels on SR → Ca²⁺ release → troponin binding.
• The Ca²⁺ that triggers contraction is from internal stores (the SR), not from outside the cell.
• Two distinct channel types: ligand-gated (ACh receptor = Na⁺ channel on the sarcolemma) and voltage-gated (Ca²⁺ channel on the SR).

Common Mistakes

• Saying "Ca²⁺ enters the cell" as the next step after ACh binding — the ion that enters first is Na⁺, not Ca²⁺.
• Confusing the sarcoplasmic reticulum with the sarcoplasm — the SR is a separate membrane-bound compartment, not the cytoplasm.
• Omitting the T-tubule step, or saying the action potential "diffuses through the cell".
• Saying "Ca²⁺ channels on the sarcolemma" — the channels on the SR membrane are a different population from those on the sarcolemma.

Things to Be Careful About

• "Voltage-gated" is a specific mark-scheme requirement for the SR Ca²⁺ channels — say it.
• "Ligand-gated" is implicitly required for the ACh/Na⁺ channel pair; saying simply that "channels open" is weaker.
• The Ca²⁺ that binds to troponin is the same Ca²⁺ that flowed out of the SR — do not introduce an additional source.

Background Concept

Skeletal muscle contraction is powered by ATP, which is needed for three distinct steps:

1. The hydrolysis of ATP by the myosin head, which cocks the head into its high-energy position and provides the energy for the power stroke (the movement of actin relative to myosin).
2. The binding of a new ATP molecule to the myosin head, which causes myosin to detach from actin — without this, cross-bridges cannot break.
3. Active reuptake of Ca²⁺ into the sarcoplasmic reticulum by the SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase) pump. While Ca²⁺ remains bound to troponin, the sarcomere cannot relax.

Glucose is the principal respiratory substrate for most cells, including skeletal muscle. A low blood glucose concentration (hypoglycaemia) means less glucose reaches the muscle cells by facilitated diffusion, so the rate of aerobic respiration (and of glycolysis) falls, and less ATP is generated per unit time. Anaerobic respiration can continue briefly but cannot sustain the ATP demand of active muscle.

Understanding the Question

The command word is "suggest" — you are being asked to apply what you know about muscle contraction to a new scenario (low blood glucose). The stem tells you the link exists; you must construct the mechanism. Three marks means three distinct creditable points. The most common correct chain is: low glucose → less respiration → less ATP → Ca²⁺ not pumped back into SR → sarcomere cannot relax. The less obvious step is the role of ATP in relaxation, which many students miss — without ATP, the muscle cannot let go.

Approach

Start at the top of the chain (substrate availability) and work down to the sarcomere level. Show that ATP has at least two critical roles in the sarcomere, both of which are compromised by a fall in ATP supply: powering the power stroke and reuptake of Ca²⁺ into the SR.

Step-by-Step Reasoning

• Low blood glucose reduces the substrate available for respiration in the muscle cell. With less glucose, the rate of glycolysis, the link reaction, Krebs cycle and oxidative phosphorylation all decrease, so the rate of ATP synthesis falls.
• ATP is required by the SERCA pump to actively transport Ca²⁺ from the sarcoplasm back into the lumen of the sarcoplasmic reticulum. Without sufficient ATP, this pump runs slowly (or not at all), so Ca²⁺ accumulates in the sarcoplasm and remains bound to troponin.
• Because troponin stays bound to Ca²⁺, tropomyosin remains displaced from the myosin-binding sites on actin, so myosin heads continue to form cross-bridges. The sarcomere is therefore permanently contracted and cannot relax — this is essentially rigor. (The mark scheme accepts "paralysis" as an alternative wording.)
• Additionally, with less ATP available, the hydrolysis of ATP by the myosin head (which powers the power stroke) is reduced, so the speed of sarcomere shortening and the force of contraction are reduced; and the detachment step (which needs a new ATP to bind) is also impaired, so cross-bridges are not broken efficiently.
• Both directions of effect are valid to mention: failure of relaxation (the more obvious answer) and weaker/slower contraction (the alternative).

Key Takeaways

• ATP is required both for contraction and for relaxation.
• Without ATP, Ca²⁺ cannot be pumped back into the SR, so the sarcomere stays contracted.
• Rigor mortis after death is the real-world illustration of ATP depletion in muscle — exactly the situation this question describes.

Common Mistakes

• Stating that there is "less energy" without naming ATP — the marking point requires the word ATP.
• Forgetting that relaxation requires ATP, and saying only that contraction will slow down.
• Saying the muscle "weakens" without explaining the mechanism.
• Saying "no respiration" (rather than "decreased respiration") — muscle can still respire other substrates, and anaerobic respiration can continue briefly.

Things to Be Careful About

• The mark scheme accepts either "permanently contracted / cannot relax" or "slower / weaker contraction" — give the first as the main point and the second as a bonus if room allows.
• "Rigor" or "paralysis" are credited, but be ready to justify the term.
• The question says "low blood glucose", not "no glucose" — the appropriate phrasing is "decreased rate of respiration" or "less ATP produced", not an absolute zero.